Scarica l'app Stockscreener
44.63
0.45%
-0.20
Tarsus Pharmaceuticals Inc Azioni (TARS) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
| Revenues |
111.18%
27.61
|
13.08 | 1.871 | - | 2.50 |
Operating Expenses
|
13.51%
65.30
|
57.53 | 42.81 | 32.82 | 27.45 |
| Interest Income/Expense |
0.61%
0.983
|
0.989 | 0.858 | 0.815 | 0.684 |
| Benefits Costs and Expenses |
29.92%
65.30
|
50.26 | 42.81 | 32.82 | 29.95 |
| Costs And Expenses |
29.92%
65.30
|
50.26 | 42.81 | 32.82 | 27.45 |
| Operating Income/Loss |
15.22%
-37.68
|
-44.45 | -40.94 | -32.82 | -24.95 |
| Nonoperating Income/Loss |
23.35%
1.953
|
2.548 | 1.787 | 1.397 | 1.533 |
| Income/Loss From Continuing Operations Before Tax |
1.34%
-37.68
|
-37.19 | -40.94 | -31.42 | -23.42 |
| Income/Loss From Continuing Operations After Tax |
14.73%
-35.73
|
-41.90 | -39.15 | -31.42 | -23.42 |
|
Net Income/Loss
|
14.73%
-35.73
|
-41.90 | -39.15 | -31.42 | -23.42 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
2,579%
35.30
|
1.3178 | 30.62 | 26.82 | 26.74 |
| Diluted Average Shares |
2,579%
35.30
|
1.3178 | 30.62 | 26.82 | 26.74 |
| Basic Earnings Per Share |
20.47%
-1.01
|
-1.27 | -1.28 | -1.17 | -0.88 |
| Diluted Earnings Per Share |
20.47%
-1.01
|
-1.27 | -1.28 | -1.17 | -0.88 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
3.66%
1.11%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):